← Back to Search

Diagnostic Tests for Fainting ((POST10) Trial)

N/A

Waitlist Available

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥1 syncope in the prior 12 months

Age >50 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 2 years

Awards & highlights

(POST10) Trial Summary

This trial will compare two methods of diagnosing syncope in older patients to see which is better at providing an earlier and more accurate diagnosis.

Who is the study for?

This trial is for people over 50 who've fainted at least once in the past year and don't know why, even after a check-up and heart tracing. They should be generally healthy enough to participate for a year. It's not for those with certain heart conditions, epilepsy, recent heart attacks, or existing pacemakers.Check my eligibility

What is being tested?

The study compares two methods to diagnose unexplained fainting in older adults: a tilt table test that checks how your body responds to changes in position versus an implantable device that continuously records your heart's activity.See study design

What are the potential side effects?

Possible side effects from the tilt table test include dizziness or fainting during the procedure. The implantable loop recorder may cause discomfort or infection at the insertion site but these are typically rare.

(POST10) Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have fainted at least once in the last year.

Select...

I am over 50 years old.

(POST10) Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The will be the determination of the diagnosis of the cause of syncope (PRECIS2 criterion 8, 5/5) within 2 years.

Secondary outcome measures

cost from the perspective of the health care system

psychometric quality of life

sex and gender, and patient preferences.

(POST10) Trial Design

1Treatment groups

Experimental Treatment

Group I: All eligible participantsExperimental Treatment2 Interventions

All eligible participants are randomly assigned to one of two interventions- early Head-Up Tilt Table procedure or early Implantable Loop Recorder. The assignment is random and at a 1:1 ratio between the two strategies. Interventions: Diagnostic Test: Head Up Tilt Table (HUT) Device: Implantable Loop Recorder

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

791 Previous Clinical Trials

868,590 Total Patients Enrolled

Media Library

Device: Implantable Loop Recorder Clinical Trial Eligibility Overview. Trial Name: NCT05776810 — N/A

Fainting Research Study Groups: All eligible participants

Fainting Clinical Trial 2023: Device: Implantable Loop Recorder Highlights & Side Effects. Trial Name: NCT05776810 — N/A

Device: Implantable Loop Recorder 2023 Treatment Timeline for Medical Study. Trial Name: NCT05776810 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the patient eligibility for this research encompass those under 70 years of age?

"According to the prerequisites for enrolment, participants in this clinical trial must be aged between 50 and 110 years."

Answered by AI

Could I qualify to be involved in this experiment?

"The requirements for enrolment in this clinical trial are to be aged between 50 and 110 years old, as well as having a history of syncope. In total, 144 participants will take part in the study."

Answered by AI

Is the enrollment period for this scientific experiment still open?

"From the details found on clinicaltrials.gov, this medical experiment is no longer taking additional patients; it was first advertised in May 1st 2023 and last updated March 17th 2023. However, 27 other studies are actively enrolling at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial

2023. "Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05776810.